Alysson Muotri is professor of pediatrics and of cellular and molecular medicine at the University of California, San Diego. He also co-directs the Stem Cell Program at the university’s Moores Cancer Center.

Alysson Muotri
Associate professor
University of California, San Diego
From this contributor
With tweaks, brains in a dish may yield clear clues to autism
‘Mini-brains’ created in a dish may reveal autism’s roots and point to treatments, but they do not yet mirror some critical features of a human brain.

With tweaks, brains in a dish may yield clear clues to autism
Questions for Alysson Muotri: Applying autism tools to Zika
Mini-brains grown from stem cells in culture can reveal the effects of both autism and the Zika virus on early development.

Questions for Alysson Muotri: Applying autism tools to Zika
Explore more from The Transmitter
Machine learning spots neural progenitors in adult human brains
But the finding has not settled the long-standing debate over the existence and extent of neurogenesis during adulthood, says Yale University neuroscientist Juan Arellano.

Machine learning spots neural progenitors in adult human brains
But the finding has not settled the long-standing debate over the existence and extent of neurogenesis during adulthood, says Yale University neuroscientist Juan Arellano.
Xiao-Jing Wang outlines the future of theoretical neuroscience
Wang discusses why he decided the time was right for a new theoretical neuroscience textbook and how bifurcation is a key missing concept in neuroscience explanations.
Xiao-Jing Wang outlines the future of theoretical neuroscience
Wang discusses why he decided the time was right for a new theoretical neuroscience textbook and how bifurcation is a key missing concept in neuroscience explanations.
Memory study sparks debate over statistical methods
Critics of a 2024 Nature paper suggest the authors failed to address the risk of false-positive findings. The authors argue more rigorous methods can result in missed leads.

Memory study sparks debate over statistical methods
Critics of a 2024 Nature paper suggest the authors failed to address the risk of false-positive findings. The authors argue more rigorous methods can result in missed leads.